215 Publications (Page 8 of 9)
2003
Synthesis of MMP inhibitor radiotracer [11C]CGS 25966, a new potential pet tumor imaging agent
Fei, XiangshuFei, XiangshuZheng, Qi‐HuangZheng, Qi‐HuangLiu, XuanLiu, XuanWang, Ji‐QuanWang, Ji‐QuanStone, K. LeeStone, K. LeeMiller, Kathy DMiller, Kathy DSledge, George WSledge, George WHutchins, Gary D and Hutchins, Gary D
Journal of Labelled Compounds and Radiopharmaceuticals, vol. 46, (no. 4), pp. 351, 30 March 2003. | Journal Article
 
Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.
Fei, XiangshuZheng, Qi HLiu, XuanWang, Ji QSun, Hui BMock, Bruce HStone, K LMiller, Kathy DSledge, George W and Hutchins, Gary D
Bioorganic & medicinal chemistry letters, vol. 13, (no. 13), pp. 2217-22, 2003/Jul/7. | Journal Article
 
Thermoacoustic molecular imaging of small animals.
Kruger, Robert AKiser, William LReinecke, Daniel RKruger, Gabe A and Miller, Kathy D
Molecular imaging : official journal of the Society for Molecular Imaging, vol. 2, (no. 2), pp. 113-23, 2003/Apr. | Journal Article
 
The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era.
Miller, Kathy DSweeney, C J and Sledge, G W
Annals of Oncology, vol. 14, (no. 1), pp. 20-8, 2003/Jan. | Journal Article
2002
[11C]Choline as a potential PET marker for imaging of breast cancer athymic mice.
Zheng, Qi-HuangZheng, Qi HuangStone, K.LeeStone, K LMock, Bruce HMock, Bruce HMiller, Kathy DMiller, Kathy DFei, XiangshuFei, XiangshuLiu, XuanLiu, XuanWang, Ji-QuanWang, Ji-QuanGlick-Wilson, Barbara EGlick-Wilson, Barbara ESledge, George WSledge, George WHutchins, Gary D and Hutchins, Gary D
Nuclear medicine and biology, vol. 29, (no. 8), pp. 803-7, 2002/Nov. | Journal Article
 
Angiogenesis and antiangiogenic therapy
Sledge, Jr, George W and Miller, Kathy D
Current problems in cancer, vol. 26, (no. 1), pp. 1, 2002 Jan-Feb. | Journal Article
 
Angiogenesis and antiangiogenic therapy.
Sledge, George W and Miller, Kathy D
Current Problems in Cancer, vol. 26, (no. 1), pp. 1-60, 2002 Jan-Feb. | Journal Article
 
Angiogenesis and Antiangiogenic Therapy
Sledge, George W and Miller, Kathy D
Current Problems in Cancer, vol. 26, (no. 1), pp. 59, 2002. | Journal Article
 
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer.
Miller, Kathy DGradishar, William JSchuchter, LSparano, Joseph ACobleigh, MRobert, NRasmussen, H and Sledge, George W
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. , vol. 13, (no. 8), pp. 1220-4, 2002/Aug. | Journal Article
 
Combined anti-microtubule therapy: a phase II study of weekly docetaxel plus estramustine in patients with metastatic breast cancer.
Soule, S EMiller, Kathy DPorcu, PierluigiAnsari, RFata, FMcClean, J WZon, RSledge, G W and Einhorn, L H
Annals of Oncology, vol. 13, (no. 10), pp. 1612-5, 2002/Oct. | Journal Article
 
HER-2/neu expression in germ cell tumours
Soule, SBaldridge, LKirkpatrick, KCheng, LGilbert, J LSmith, L RThurston, V CVance, G HEinhorn, L and Miller, K
Journal of Clinical Pathology, vol. 55, (no. 9), Sep 2002. | Journal Article
 
Issues and challenges for antiangiogenic therapies
Miller, Kathy D
Breast Cancer Research and Treatment, vol. 75, pp. S45, Oct 2002. | Journal Article
 
Issues and challenges for antiangiogenic therapies.
Miller, Kathy D
Breast cancer research and treatment. , vol. 75 Suppl 1, pp. S45-50; discussion S57-8, 2002/Oct. | Journal Article
 
Issues and challenges for antiangiogenic therapies.
Miller, Kathy D
Breast Cancer Research and Treatment, vol. 75 Suppl 1, pp. S45-50; discussion S57-8, 2002/Oct. | Journal Article
 
Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents.
Zheng, Qi HuangFei, XiangshuLiu, XuanWang, Ji-QuanBin Sun, HuiMock, Bruce HLee Stone, KMartinez, Tanya DMiller, Kathy DSledge, George W and Hutchins, Gary D
Nuclear medicine and biology, vol. 29, (no. 7), pp. 761-70, 2002/Oct. | Journal Article
 
Synthesis of MMP inhibitor radiotracers [11C]methyl‐CGS 27023A and its analogs, new potential PET breast cancer imaging agents
Fei, XiangshuFei, XiangshuZheng, Qi‐HuangZheng, Qi‐HuangHutchins, Gary DHutchins, Gary DLiu, XuanLiu, XuanStone, K. LeeStone, K. LeeCarlson, Kathy ACarlson, Kathy AMock, Bruce HMock, Bruce HWinkle, Wendy LWinkle, Wendy LGlick‐Wilson, Barbara EGlick‐Wilson, Barbara EMiller, Kathy DMiller, Kathy DFife, Rose SFife, Rose SSledge, George WSledge, George WSun, Hui BinSun, Hui BinCarr, Raymond E and Carr, Raymond E
Journal of Labelled Compounds and Radiopharmaceuticals, vol. 45, (no. 6), pp. 470, May 2002. | Journal Article
 
Synthesis of radiolabeled O6‐benzylguanine derivatives as new potential PET tumor imaging agents for the DNA repair protein O6‐alkylguanine‐DNA alkyltransferase
Zheng, Qi‐HuangZheng, Qi‐HuangLiu, XuanLiu, XuanFei, XiangshuFei, XiangshuWang, Ji‐QuanWang, Ji‐QuanOhannesian, David WOhannesian, David WErickson, Leonard CErickson, Leonard CStone, K. LeeStone, K. LeeMartinez, Tanya DMartinez, Tanya DMiller, Kathy DMiller, Kathy DHutchins, Gary D and Hutchins, Gary D
Journal of Labelled Compounds and Radiopharmaceuticals, vol. 45, (no. 14), pp. 1252, December 2002. | Journal Article
2001
Adjuvant chemotherapy for tumors of one centimeter or less: the law of diminishing returns.
Soule, S E and Miller, K D
Current oncology reports, vol. 3, (no. 6), pp. 529-535, November 2001. | Journal Article
 
Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.
Miller, Kathy DSisk, JAnsari, RGize, GNattam, SPennington, KMonaco, F and Sledge, George W
Oncology, vol. 15, (no. 2 Suppl 3), pp. 38-40, 2001/Feb. | Journal Article
 
Redefining the target: chemotherapeutics as antiangiogenics.
Miller, Kathy DSweeney, Christopher J and Sledge, George W
Journal of Clinical Oncology, vol. 19, (no. 4), pp. 1195-206, 2001/Feb/15. | Journal Article
 
Selection bias in clinical trials.
Miller, Kathy DRahman, Z U and Sledge, G W
Breast disease. , vol. 14, pp. 31-40, 2001. | Journal Article
 
The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.
Sweeney, Christopher JMiller, Kathy DSissons, S ENozaki, SHeilman, D KShen, J and Sledge, George W
Cancer Research, vol. 61, (no. 8), pp. 3369-72, 2001/Apr/15. | Journal Article
2000
A Phase II trial of high dose epirubicin in patients with advanced breast carcinoma
Miller, Kathy DMiller, Kathy DMunshi, NikhilMunshi, NikhilLoesch, DavidLoesch, DavidEinhorn, Lawrence HEinhorn, Lawrence HSledge, George W and Sledge, George W
Cancer, vol. 88, (no. 2), pp. 380, 15 January 2000. | Journal Article
 
Breast cancer in vivo: contrast enhancement with thermoacoustic CT at 434 MHz-feasibility study.
Kruger, Robert AMiller, K DReynolds, H EKiser, W LReinecke, D R and Kruger, G A
Radiology, vol. 216, (no. 1), pp. 279-83, 2000/Jul. | Journal Article
 
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial.
Quella, S KLoprinzi, Charles LBarton, Debra LKnost, J ASloan, Jeff ALaVasseur, B ISwan, DKrupp, K RMiller, K D and Novotny, P J
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 18, (no. 5), pp. 1068-74, 2000/Mar. | Journal Article